| 11/9/2018 | BKCAHY | S&P affirms Bausch Health
|
| 8/23/2018 | BKCADDHY | Moody’s ups Bausch SGL, changes view
|
| 6/20/2018 | BKCVDDEMIGPV | Market Commentary: Intelsat dominates trading; PHI recoups losses; Valeant Pharmaceuticals active
|
| 5/25/2018 | BKCVDDEMIGPV | Market Commentary: Primary market quiet pre-holiday; forward calendar light; California Resources in focus
|
| 5/21/2018 | BKCVDDEMIGPV | Market Commentary: Graham Holdings, Atotech on tap; Ithaca Energy, JW Aluminum delayed; EP Energy dominates
|
| 5/18/2018 | BKCVDDEMIGPV | Market Commentary: EP Energy, BWX prices; Valeant trades up; Hearthside, SRS struggle; Sprint tanks
|
| 5/17/2018 | BKCVDDEMIGPV | Market Commentary: Valeant, Hearthside, SRS, others price; GFL, WeWork struggle again; funds lose $542 million
|
| 5/17/2018 | BKCADDHY | Moody’s rates Valeant notes Caa1
|
| 5/16/2018 | BK | Market Commentary: Summit, Jordan, Berry break; Valeant, Quest, Omnia, Pinnacle, Hillman and more updated
|
| 5/16/2018 | BK | Valeant ups term B to $4.57 billion, spread now Libor plus 300 bps
|
| 5/15/2018 | BKCAHY | Moody’s rates Valeant loans Ba3
|
| 5/14/2018 | BK | Market Commentary: Jordan Health, BI-LO, Power Products revised; Valeant, Telenet, Open Text and more set talk
|
| 5/14/2018 | BKCAHY | S&P rates Valeant loans BB-, notes B-
|
| 5/14/2018 | BK | Valeant launches $3.8 billion term loan B at Libor plus 325 bps
|
| 5/10/2018 | BKCVDDEMIGPV | Market Commentary: Nemaska prices; Hearthside, Valeant join calendar; MDC tanks; funds add $0.76 billion
|
| 5/10/2018 | BK | Market Commentary: Aristocrat, GFL, Bright Horizons break; Vistra Energy, American Airlines, TerraForm update
|
| 5/10/2018 | BK | Valeant to launch $5.02 billion credit facilities on Monday
|
| 5/8/2018 | BKCVDDEMIGPV | Market Commentary: Primary quiet; Gaming & Leisure active; Dish volatile; Sanchez Energy drops, Valeant gains
|
| 5/8/2018 | BKBWCAHYLM | Valeant cuts debt by $6.9 billion since 2016; ‘more work to be done’
|
| 3/16/2018 | BKCVDDEMIGPV | Market Commentary: Tullow, Husky lead busy primary; Mattel trades on Toys shutdown; Teva still trades under par
|
| 3/15/2018 | BKCVDDEMIGPV | Market Commentary: Live Nation, Aker price new deals; new Guitar Center active; funds gain $11 million
|
| 3/14/2018 | BKCVDDEMIGPV | Market Commentary: Guitar Center, NVA bring deals; U.S. Steel, J.C. Penney dominate secondary; Valeant busy
|
| 3/13/2018 | BKCVDDEMIGPV | Market Commentary: U.S. Steel prices $650 million; new Valeant dominates secondary; recent Frontier active
|
| 3/12/2018 | BKCVDDEMIGPV | Market Commentary: Valeant, American Axle price; Frontier, J.C. Penney new issues continue activity
|
| 3/12/2018 | BKCAHY | Fitch gives B-/RR4 to Valeant notes
|
| 3/12/2018 | BKCAHY | Moody’s rates Valeant notes Caa1
|
| 3/6/2018 | BKCAHY | Fitch rates Valeant, facility, notes
|
| 2/28/2018 | BKCVDDEMIGPV | Market Commentary: Warner Music, Kennedy-Wilson add-on price; Sprint continues to dominate secondary
|
| 2/28/2018 | BKBWCAHY | Valeant cuts debt to $25.5 billion; further debt cuts planned in 2018
|
| 1/25/2018 | BK | Valeant to pay down additional $200 million of senior secured loans
|
| 1/5/2018 | BKCVDDEMIGPV | Market Commentary: Primary quiet as junk closes year’s first week, pick up expected; oil names ease
|
| 1/3/2018 | BK | Valeant Pharmaceuticals repays $300 million of senior secured loans
|
| 1/2/2018 | BKCVDDEMIGPV | Market Commentary: Junk primary quiet as 2018 opens; CalRes rises with crude; Chesapeake up with gas prices
|
| 12/22/2017 | BKCVDDEMIGPV | Market Commentary: Junk quiet pre-holiday; Medical Properties Trust off, Valeant up; Kindred ends week up
|
| 12/21/2017 | BKCVDDEMIGPV | Market Commentary: Primary quiet as holiday nears; CalRes, Valeant, Mattel up; funds lose $1.11 billion
|
| 12/12/2017 | BKCVDDEMIGPV | Market Commentary: Upsized Whiting megadeal, Iron Mountain lead $2.63 billion day; more PetSmart punishment
|
| 12/11/2017 | BKCVDDEMIGPV | Market Commentary: NFP prices add-on; Standard does a split-rate; recent Valeant again firms; Algeco up
|
| 12/8/2017 | BKCVDDEMIGPV | Market Commentary: ACE Cash, Itron, revamped BMC close $11.2 billion primary week; new Jeld-Wen busy
|
| 12/6/2017 | BKCVDDEMIGPV | Market Commentary: Primary pace slackens as Mercer brings sole dollar deal; Claire’s climbs on results
|
| 12/5/2017 | BKCVDDEMIGPV | Market Commentary: Quicken megadeal paces second straight $3.5 billion day; heavy trading in new Valeant
|
| 12/4/2017 | BKCVDDEMIGPV | Market Commentary: Valeant, Continental Resources megadeals lead $3.5 billion session; energy surges
|
| 12/4/2017 | BKCAHY | S&P rates Valeant Pharmaceuticals notes B-
|
| 12/4/2017 | BKCADDHY | Moody’s gives Valeant notes Caa1
|
| 11/15/2017 | BKCVDDEMIGPV | Market Commentary: Centennial is lone pricing as primary calms down; Murray slides as Bowie buyout dies
|
| 11/15/2017 | BK | Market Commentary: Advanced Disposal, Valeant, Entercom, National Vision, Outfront, Playa and more break
|
| 11/14/2017 | BKCVDDEMIGPV | Market Commentary: Lennar megadeal, Valeant add-on pace $3.8 billion primary day; energy names off
|
| 11/13/2017 | BKCVDDEMIGPV | Market Commentary: Resolute deal on, then off; Valeant shops add-on; Rite Aid firms; market weakens
|
| 11/13/2017 | BK | Valeant to repay series F tranche B term loans via new note add-on
|
| 11/9/2017 | BK | Market Commentary: First Data, Seahawk, Burlington, Utility One break; Avaya, Intralinks, Chassix set changes
|
| 11/9/2017 | BK | Valeant launches term loan B repricing at Libor plus 350 bps
|
| 11/8/2017 | BKCADDHY | Moody’s revises Valeant to stable
|
| 11/7/2017 | BKCVDDEMIGPV | Market Commentary: Primary quiets, but Michael Baker slates deal; new QEP steady; Windstream falls; oils jump
|
| 11/7/2017 | BKBWHY | Valeant touts progress on debt cutting, reaches $5 billion pay-down target sooner than expected
|
| 10/31/2017 | BK | Valeant to pay down $125 million more on senior secured term loans
|
| 10/3/2017 | BKCVDDEMIGPV | Market Commentary: Downsized West, upsized Energy Transfer and PBF add-on price; existing Valeants fall
|
| 10/2/2017 | BKCVDDEMIGPV | Market Commentary: Crown Rock, Valeant, Scientific Games drive by; new Caesars notes busy, Murray up
|
| 10/2/2017 | BKCAHY | S&P rates Valeant notes BB-
|
| 10/2/2017 | BKCAHY | Moody’s gives Valeant notes Ba3
|
| 9/29/2017 | BKCVDDEMIGPV | Market Commentary: Caesars prices $1.7 billion, gains in trading; Jonah stays firm; Valeant up on asset sale
|
| 9/29/2017 | BK | Valeant to repay term loan debt with $930 million iNova sale proceeds
|
| 9/25/2017 | BKBWCVDDHY | Valeant may lower ‘hefty’ debt through equity-linked securities sale
|
| 8/9/2017 | BKCVDDEMIGPV | Market Commentary: TMS Int’l, David Weekly, Clear Channel Outdoor price; Hertz higher, Valeant gives up gains
|
| 8/8/2017 | BKCVDDEMIGPV | Market Commentary: Upsized Restaurant Brands megadeal, Triumph and WPX price; new Dynegy busy; Valeant jumps
|
| 8/8/2017 | BK | Market Commentary: TransDigm dips with new loan launch; Valeant rises; United Site, Constellis set changes
|
| 8/8/2017 | BKBWDDHY | Valeant says will achieve $5 billion debt-reduction goal ahead of scheduled February 2018 target
|
| 7/17/2017 | BKCVDDEMIGPV | Market Commentary: Lithia prices, rises; new Hovnanians continue climb; Valeant firms on asset-sale news
|
| 7/17/2017 | BK | Valeant Pharmaceuticals to repay term loan with Obagi sale proceeds
|
| 7/10/2017 | BK | Valeant repays $811 million senior secured term loans via asset sale
|
| 6/22/2017 | BKCVDDEMIGPV | Market Commentary: J2 prices; Senate bill drives health higher; Rite Aid lower on report; funds out $128 million
|
| 6/9/2017 | BKCVDDEMIGPV | Market Commentary: Navient add-on caps nearly $6 billion week; new HCA firms; Rite Aid slide continues
|
| 6/8/2017 | BKCVDDEMIGPV | Market Commentary: HCA split-rated deal prices; recent issues easier; Valeant up on asset sale; funds gain
|
| 6/7/2017 | BKBWHY | Valeant CEO says debt paydown gives company ‘runway’ for turnaround
|
| 5/1/2017 | BKCVDDEMIGPV | Market Commentary: USG, New Home drive by; Covey Park active; Pharmaceutical Product about flat; Petsmart up
|
| 5/1/2017 | BK | Valeant pays down roughly $220 million on senior secured term loans
|
| 4/18/2017 | BKCVDDEMIGPV | Market Commentary: Cumberland prices; Petsmart surges after Chewy acquisition; Post up a bit; pharma down
|
| 4/12/2017 | BKCVDDEMIGPV | Market Commentary: SNF Floerger, Tutor Perini, Endo, Tennant price; Toys ‘R’ Us jumps; recent issues mixed
|
| 3/30/2017 | BKCADDHY | Moody’s ups Valeant to SGL-2
|
| 3/21/2017 | BKCVDDEMIGPV | Market Commentary: Valeant down on lower session; Petsmart follows; recent First Quantum and AK Steel fall
|
| 3/15/2017 | BKCVDDEMIGPV | Market Commentary: Eldorado prices, firms; Foresight, Quantum deals on tap; market firms after Fed rate move
|
| 3/14/2017 | BKCVDDEMIGPV | Market Commentary: Primaryside focus turned to Europe; new T-Mobile, AMC deals active; new Valeant retreats
|
| 3/14/2017 | BK | Market Commentary: Valeant, Arctic Glacier, Camping World, Navico free to trade; Horizon Pharma terms surface
|
| 3/13/2017 | BKCVDDEMIGPV | Market Commentary: T-Mobile three-part megadeal, AMC drive by, new AMC gains; new Valeant again firm
|
| 3/10/2017 | BKCVDDEMIGPV | Market Commentary: New Home, Fortress price to cap $17.54 billion week, biggest of all time, recent deals busy
|
| 3/9/2017 | BKCVDDEMIGPV | Market Commentary: Valeant, American Axle, Charter lead year’s biggest day so far; funds plunge $2.12 billion
|
| 3/9/2017 | BK | Market Commentary: Avantor, Hilton, Boyd, Caraustar, SRAM break; Aramark, HCA, Allnex, Valeant update deals
|
| 3/9/2017 | BKCAHY | S&P provides BB- to Valeant notes
|
| 3/6/2017 | BKCVDDEMIGPV | Market Commentary: Aircastle, Olin, Vermilion price; calendar swells; new Blue Line, CyrusOne busy
|
| 3/6/2017 | BK | Market Commentary: Navios, Atrium Innovations, Aspen Dental break; Valeant term F dips; Allnex makes changes
|
| 3/6/2017 | BKCAHY | Moody’s rates Valeant facilities, notes Ba3
|
| 3/6/2017 | BK | Valeant Pharmaceuticals launches $3.06 billion series F-3 term loan B
|
| 3/1/2017 | BKCVDDEMIGPV | Market Commentary: Dollar pricings again absent, but BlueLine, Vermilion slate; Avis prices euro deal
|
| 2/28/2017 | BKCVDDEMIGPV | Market Commentary: Dollar primary still on hold, Stonegate to shop sterling deal; Intelsat adds to gains
|
| 1/20/2017 | BK | Market Commentary: TransDigm hit on short-seller report; Cengage, McGraw-Hill loans tumble; inflows continue
|
| 1/20/2017 | BK | TransDigm re-evaluates deal timing after short-seller’s warning
|
| 1/11/2017 | BKCVDDEMIGPV | Market Commentary: Novalex prices; Team Health ahead; Valeant down; other pharma companies follow; E&P mixed
|
| 1/10/2017 | BKCVDDEMIGPV | Market Commentary: Novolex on tap, Icahn on the road; Sabine Pass up on ratings boost, Valeant on asset sale
|
| 1/10/2017 | BK | Market Commentary: Ascena dips with sales results; Valeant up on asset sale plans; Synchronoss revises deadline
|
| 1/10/2017 | BK | Valeant to permanently repay term loan debt with asset sale proceeds
|
| 12/13/2016 | BKCVDDEMIGPV | Market Commentary: Upsized AmeriGas, Concho, American Midstream price; recent RSP Permian, Carlson trade up
|
| 11/30/2016 | BK | Market Commentary: Zayo, Electric Lightwave react to acquisition news; Valeant weakens; Save-A-Lot tweaks deal
|
| 11/23/2016 | BKCVDDEMIGPV | Market Commentary: Firmer junk market quietly heads into holiday break; Conduent paper well above issue price
|
| 11/15/2016 | BKBWCADDHYLM | Valeant aims to pay $5 billion of $30 billion debt via asset sales
|
| 11/8/2016 | BKCVDDEMIGPV | Market Commentary: Primary stays quiet, Telesat Canada downsizes, CF deal seen high-grade; Valeant, Hertz dip
|
| 11/8/2016 | BK | Market Commentary: AssuredPartners, Netsmart, CSRA break; Hertz, Valeant slide with earnings, slashed outlooks
|
| 11/8/2016 | BKCADDHY | Moody’s lowers Valeant, facilities, debt
|
| 11/3/2016 | BKCVDDEMIGPV | Market Commentary: Downsized ServiceMaster prices, also Associated Materials, Kissner; funds dive by $4 billion-plus
|
| 11/2/2016 | BKCVDDEMIGPV | Market Commentary: Dollar primary quiets down after huge session; Telesat slates; Tutor Perini spikes deal
|
| 8/18/2016 | BKCAHY | Valeant lenders OK amendment permitting loan paydown with notes
|
| 8/11/2016 | BKCVDDEMIGPV | Market Commentary: XPO, Service King drive by, XPO gains; Community Health, Valeant lower; funds add $1.655 billion
|
| 8/11/2016 | BK | Market Commentary: XPO, Polyconcept, Continental Building, Headwaters, WaveDivision free to trade; Valeant dips
|
| 8/10/2016 | BKCVDDEMIGPV | Market Commentary: No dollar deals price, Murphy Oil slates; new MGM Growth, Builders, Veritas issues active
|
| 8/10/2016 | BK | Market Commentary: NEW Asurion, Trader, Truck Hero, Oasis break; Valeant gains; SolarWinds, WaveDision tweaked
|
| 8/10/2016 | BKCAHY | Moody’s: Valeant unchanged by amendment
|
| 8/10/2016 | BKCAHY | Valeant launches amendment to permit loan paydown with senior notes
|
| 8/9/2016 | BKCVDDEMIGPV | Market Commentary: Builders First Source leads drive-by parade, new bonds pop; Valeant jumps on results
|
| 8/9/2016 | BK | Market Commentary: Leslie’s, WCA Waste break; Walter rises; Valeant better with amendment and asset sale talk
|
| 8/9/2016 | BKBWCAHYLM | Valeant says debt-cutting remains a focus, $880 million cut since Q1, seeks covenant relief
|
| 7/8/2016 | BKCVDDEMIGPV | Market Commentary: New Transocean notes busy, better; primary quiet but hopeful; overall junk market stronger
|
| 6/10/2016 | BKCAHY | Moody’s ups Valeant liquidity
|
| 6/7/2016 | BKCVDDEMIGPV | Market Commentary: Gray TV, Six Flags drive by, Zekelman also prices, new bonds busy, higher; Valeant gyrates
|
| 6/7/2016 | BKBWHYLM | Valeant liquidity ‘solid,’ committed to $1.7 billion debt reduction
|
| 5/27/2016 | BKCVDDEMIGPV | Market Commentary: Primary quiet to end $11 billion week; Yum! slates megadeal; Valeant up on M&A buzz
|
| 5/23/2016 | BKDDHY | Valeant plans to use asset sale proceeds to tackle debt, says new CEO
|
| 5/3/2016 | BKCVHY | Moody’s lifts Valeant probability rating
|
| 5/3/2016 | BKCVHY | S&P: Valeant on positive watch
|
| 4/29/2016 | BKCVDDEMIGPV | Market Commentary: Ardagh brings $4.5 billion to strong demand; Western Digital off post-earnings; Valeant pressured
|
| 4/14/2016 | BKCVHY | S&P downgrades Valeant
|
| 4/13/2016 | BKCADDHY | Moody’s drops Valeant liquidity to SGL-4
|
| 4/7/2016 | BKCVDDEMIGPV | Market Commentary: Upsized Charter drives by, eases; new Numericable again tops actives; funds gain $1.18 billion
|
| 4/7/2016 | BK | Market Commentary: MGM Growth, Sedgwick, AssuredPartners free to trade; Valeant better with amendment approval
|
| 4/7/2016 | BK | Valeant obtains lender approval for credit facility amendment, waiver
|
| 4/6/2016 | BK | Market Commentary: Valeant gains more ground; Atlantic Power, MGM Growth, American Renal update deals
|
| 4/5/2016 | BKCVDDEMIGPV | Market Commentary: Downsized Diebold prices; new Sunoco still struggles; WDC busy again; Valeant bonds bounce
|
| 4/5/2016 | BK | Market Commentary: Diebold, Alvogen, Blount break; Valeant rises; MGM Growth Properties deal updates surface
|
| 3/31/2016 | BKCAHY | Moody’s drops Valeant, debt
|
| 3/30/2016 | BK | Market Commentary: Valeant rises with amendment; Western Digital breaks; Blount, DYK Automotive changes surface
|
| 3/30/2016 | BK | Valeant opens process of obtaining credit facility amendment, waiver
|
| 3/28/2016 | BK | Market Commentary: Valeant dips in trading as CEO summoned to testify; Precyse, NAPA Management on deck
|
| 3/21/2016 | BKCVDDEMIGPV | Market Commentary: Intelsat, Aircastle price upsized drive-by deals; Valeant bonds busy amid board turmoil
|
| 3/18/2016 | BKCVDDEMIGPV | Market Commentary: Upsized MDC prices to cap $2.57 billion week, moves up; oil names gain; busy Valeant fades
|
| 3/16/2016 | BKCVDDEMIGPV | Market Commentary: Cinemark brings add-on; Kraton Polymers relaunches deal; Radian up; Valeant again active
|
| 3/16/2016 | BK | Market Commentary: March ‘good month’ for CLOs; Valeant sparks concerns; BB, B notes active in secondary
|
| 3/16/2016 | BK | Market Commentary: Imagine! Print breaks; Valeant partially rebounds; ON Semiconductor changes surface
|
| 3/16/2016 | BKCAHY | S&P: Valeant on negative watch
|
| 3/16/2016 | BKCAHY | Moody’s lowers Valeant, loans, notes
|
| 3/15/2016 | BKCVDDEMIGPV | Market Commentary: Radian prices, new bonds pop, recent deals steady; Valeant down on warning, lower guidance
|
| 3/15/2016 | BK | Market Commentary: Windstream breaks; Neiman up with earnings; Valeant falls on numbers, guidance changes
|
| 3/15/2016 | BKBWCAHY | Valeant in covenant compliance now but faces reporting breaches; ‘comfortable’ with liquidity
|
| 3/15/2016 | BKCADDHY | Valeant delays 10-K, breaching covenants and opening door to default
|
| 3/2/2016 | BK | Market Commentary: Valeant Pharmaceuticals’ term debt rebound continues; ON Semiconductor loan on deck
|
| 3/1/2016 | BKCVDDEMIGPV | Market Commentary: Upsized HCA megadeal drives by, bonds rise; new Solera strong; Valeant rebounds
|
| 3/1/2016 | BK | Market Commentary: Valeant Pharmaceuticals sees some improvement; Solera gains; HCA reworks term loan size
|
| 2/29/2016 | BKCVDDEMIGPV | Market Commentary: Restructured Solera deal prices; new Lennar busy; Valeant dives on SEC probe, Intelsat off
|
| 2/29/2016 | BKCAHY | Moody’s reviews Valeant
|
| 2/23/2016 | BKCVDDEMIGPV | Market Commentary: Summit Materials drives by; Solera sets talk; Valeant rebounds, but Intelsat slide worsens
|
| 2/23/2016 | BK | Market Commentary: Valeant regains some ground; PetSmart slides with dividend payment; GCA Services rises
|
| 2/23/2016 | BKCAHY | Moody’s changes Valeant to negative
|
| 1/7/2016 | BKCVDDEMIGPV | Market Commentary: Microsemi brings year’s first syndicated new deal; market lower, funds lose $809 million
|
| 1/5/2016 | BKCVDDEMIGPV | Market Commentary: Junk steadies after opening 2016 with loss; Chesapeake gains, primary calm, but M&A deals expected
|
| 12/22/2015 | BKCVDDEMIGPV | Market Commentary: Junk sees improved tone, helped by better stocks, oil prices; Valeant up; Denbury down
|
| 12/17/2015 | BKCVDDEMIGPV | Market Commentary: Two-day junk rally ends; oils lower; Valeant mixed, Navistar up; funds plunge $3.81 billion
|
| 12/16/2015 | BKCVDDEMIGPV | Market Commentary: Junk rally continues as Fed hikes rates, primary remains quiet; Valeant extends gains
|
| 12/16/2015 | BKCAHY | Valeant updates on guidance, aims to chop leverage to 4.0 times area
|
| 12/15/2015 | BKCVDDEMIGPV | Market Commentary: Primary still quiet as junk turns broadly higher; Valeant jumps on Walgreens arrangement
|
| 12/15/2015 | BK | Market Commentary: Valeant rises with Walgreens agreement; Konecranes Terex frees up; MB Aerospace updated
|
| 11/10/2015 | BKCVDDEMIGPV | Market Commentary: Teekay, ContourGlobal bring add-ons in quiet pre-holiday session; Valeant firms after call
|
| 11/10/2015 | BKBWHY | Valeant says debt reduction a key priority, will use ‘lion’s share’ of cash flow to de-lever
|
| 11/9/2015 | BKCVDDEMIGPV | Market Commentary: HCA megadeal prices, trades actively; Team Health, ContourGlobal slate; market moves lower
|
| 11/3/2015 | BKCVDDEMIGPV | Market Commentary: CNH, Platform Specialty Products price; Platform pops; new T-Mobile jumps on heavy volume
|
| 10/30/2015 | BKCVDDEMIGPV | Market Commentary: Primary quiet to close out $6 billion week, $9.4 billion month; Thursday deals rise in heavy trading
|
| 10/30/2015 | BK | Market Commentary: First Eagle Investment breaks; Valeant term loans slide; T-Mobile moves up deadline to Monday
|
| 10/28/2015 | BKCVDDEMIGPV | Market Commentary: Primary quiet, but new L Brands bonds jump; Bombardier flies on government aid report
|
| 10/27/2015 | BKCVDDEMIGPV | Market Commentary: L Brands, Toll drive by; Rite Aid jumps on Walgreens buyout news; Valeant bonds turn mixed
|
| 10/27/2015 | BKCAHY | S&P revises Valeant to negative
|
| 10/26/2015 | BKCVDDEMIGPV | Market Commentary: Valeant bonds fall despite company’s presentation; Chesapeake chopped on gas price weakness
|
| 10/26/2015 | BK | Market Commentary: Panda Hummel frees up; Valeant softens; handful of companies ready launches for this week
|
| 10/26/2015 | BKCAHY | Valeant forms ad hoc committee to address Philidor concerns, CEO blasts ‘false’ report
|
| 10/23/2015 | BKCVDDEMIGPV | Market Commentary: Pharmaceutical, hospital names rebound; Asbury add-on closes $1.65 billion primary week
|
| 10/22/2015 | BKCVDDEMIGPV | Market Commentary: Hospital names fall on Community Health earnings warning; funds see $3.34 billion inflow
|
| 10/21/2015 | BKCVDDEMIGPV | Market Commentary: Valeant crushed as short-seller’s report alleges fraud; Jarden prices; Globo postpones
|
| 10/21/2015 | BK | Market Commentary: Valeant Pharmaceuticals volatile on accusatory research report; Affordable Care revised
|
| 10/20/2015 | BKCAHY | Moody’s changes Valeant view to stable
|
| 10/19/2015 | BKCVDDEMIGPV | Market Commentary: Primary quiet, though American Energy – Permian on tap; new AerCap keeps firming in active trading
|
| 10/19/2015 | BK | Market Commentary: Sucampo breaks; Valeant dips on numbers; Electronic Funds rises; Weight Watchers skyrockets
|
| 10/16/2015 | BKCVDDEMIGPV | Market Commentary: AerCap parachutes in with upsized $1 billion deal, new bonds fly; Valeant, oils, Wynn all rebound
|
| 10/15/2015 | BKCVDDEMIGPV | Market Commentary: Valeant sours on subpoena, Fortescue up on debt buyback, cost cuts; funds gain $1.48 billion in week
|
| 10/5/2015 | BKCVDDEMIGPV | Market Commentary: High yield rebounds as week begins; Valeant paper fades; Cablevision, Altice climb higher
|
| 9/29/2015 | BKCVDDEMIGPV | Market Commentary: Valeant rebounds; Alcoa ends weak again; Chesapeake announces layoffs; Bombardier firms
|
| 9/29/2015 | BK | Market Commentary: Universal Fiber hikes talk on second-lien loan; chemical names softer; outflows on Monday
|
| 9/28/2015 | BKCVDDEMIGPV | Market Commentary: High-yield market ends in ‘bloodbath’; recent new issues pressured; Valeant faces subpoena
|
| 9/28/2015 | BK | Market Commentary: Loans down ¼ point Monday; Schumacher allocates; MedImpact, GTT Communications set meetings
|
| 8/20/2015 | BKCVDDEMIGPV | Market Commentary: No pricings, primary seen done for summer; new KIK, Oneok notes active; funds gain $111 million
|
| 6/25/2015 | BKCVDDEMIGPV | Market Commentary: TI Automotive prices; Endo deal adds to gains; Valeant off on M&A; funds up $621 million
|
| 5/22/2015 | BK | Market Commentary: Calpine, ClubCorp, Valeant Pharmaceuticals free to trade; LightSquared changes surface
|
| 5/20/2015 | BK | Market Commentary: Energizer, Kronos break; Virgin Media, Valeant, Infiltrator, Flint, TouchTunes tweak deals
|
| 5/20/2015 | BK | Valeant sets term D at Libor plus 275 bps, pulls term C repricing
|
| 5/14/2015 | BK | Market Commentary: CHS, Presidio, Ranpak, Acrisure break; Virgin, ClubCorp, Valeant, Connolly, Varsity launch
|
| 5/14/2015 | BK | Valeant launches term C and D repricing at Libor plus 250-275 bps
|
| 5/13/2015 | BK | Market Commentary: PetSmart, TransDigm, Arcade/Bioplan break; Aria, Ranpak update deals; CHG tweaks deadline
|
| 5/13/2015 | BK | Valeant Pharmaceuticals to launch term C and D repricing on Thursday
|
| 4/9/2015 | BKCVDDEMIGPV | Market Commentary: Fiat Chrysler, Murray deals lead $6.6 billion primary; Halcon up; funds gain $1.35 billion
|
| 4/2/2015 | BKCVHY | S&P lifts Valeant secured debt
|
| 4/1/2015 | BK | Market Commentary: Penn Products, Nortek break; CPM, Advantage Sales updates deals; Natel EMS shutting early
|
| 3/18/2015 | BKCVDDEMIGPV | Market Commentary: Infor megadeal prices; Rite Aid, Huntsman slate; still-accommodative Fed helps market firm
|
| 3/17/2015 | BKCVDDEMIGPV | Market Commentary: Virgin Media, split-rated Masco deals price, Fortescue shelves offering; energy fades more
|
| 3/16/2015 | BKCVDDEMIGPV | Market Commentary: Vulcan drives by; new Valeant bonds busy as Endo gives up on Salix; energy slide continues
|
| 3/13/2015 | BKCVDDEMIGPV | Market Commentary: Giant-sized Valeant deal caps nearly $16 billion week, new bonds busy; energy names slide
|
| 3/13/2015 | BK | Market Commentary: Valeant Pharmaceuticals, Lions Gate Entertainment, Ferrara Candy break; Fortescue weakens
|
| 3/12/2015 | BKCVDDEMIGPV | Market Commentary: United Rentals two-parter, CenturyLink price; Valeant upsizes; funds lose $1.96 billion
|
| 3/12/2015 | BK | Market Commentary: Ineos, Headwaters, Tank, Surgical Care hit secondary; Valeant, Wabash National modify deals
|
| 3/12/2015 | BK | Valeant cuts term B to $4.15 billion, flexes to Libor plus 325 bps
|
| 3/12/2015 | BK | Valeant cuts spread on $4.55 billion term loan B to Libor plus 325 bps
|
| 3/11/2015 | BKCVDDEMIGPV | Market Commentary: Shea Homes two-parter, Surgical Care, GFL deals price; Valeant up on Endo bid for Salix
|
| 3/10/2015 | BKCAHY | Moody's rates Valeant loans Ba1, notes B1
|
| 3/10/2015 | BKCAHY | S&P provides B to Valeant notes
|
| 3/9/2015 | BKCVDDEMIGPV | Market Commentary: Crestwood, Masonite, HealthSouth drive by; calendar builds; Whiting jumps on sale talk
|
| 3/9/2015 | BK | Market Commentary: Coinmach frees to trade; Tank Holding, Surgical Care revisions revealed; Valeant sets talk
|
| 3/9/2015 | BK | Valeant launches $4.55 billion term loan B at Libor plus 350 bps
|
| 3/9/2015 | BKCAHY | S&P gives BB to Valeant loans
|
| 3/5/2015 | BK | Market Commentary: Valeant kicks off $5.55 billion; Fortescue meeting Friday; loan funds see $196 million outflows
|
| 3/5/2015 | BK | Valeant kicks off $5.55 billion loan package, sets Monday bank meeting
|
| 2/24/2015 | BKCVDDEMIGPV | Market Commentary: Digicel drives by, moves up; recent bonds busy; Sitel bonds gain as Onex eyes possible sale
|
| 2/24/2015 | BK | Valeant launches amendment to permit incremental debt for Salix buy
|
| 2/23/2015 | BK | Market Commentary: Valeant dips, Ocwen up in trading; Riverbed, National Mentor, Armacell, Constantia revised
|
| 2/23/2015 | BKCVDDEMIGPV | Market Commentary: DISH weakens after numbers, CEO retirement; Salix gains on Valeant merger; Toys’ bonds up
|
| 2/23/2015 | BKHY | S&P puts Valeant on positive watch
|
| 2/23/2015 | BKCAHY | Valeant plans $15.15 billion of term loans and notes for Salix buy
|
| 1/20/2015 | BKCVDDEMIGPV | Market Commentary: Post-holiday primary cooks with Zayo, Endo, HealthSouth drive-bys; new, recent deals busy
|
| 1/15/2015 | BKCVDDEMIGPV | Market Commentary: Valeant, Targa price megadeals; Bombardier drops on plane pause; funds gain $879.5 million
|
| 1/15/2015 | BKCAHY | Moody’s rates Valeant notes B1, view positive
|
| 1/15/2015 | BKHY | S&P rates Valeant notes B
|
| 1/15/2015 | BK | Valeant Pharmaceuticals to pay down revolver debt with notes proceeds
|
| 1/8/2015 | BKBWCAHYLMLW | Valeant cuts leverage to 3.5x, holds out prospect of more debt paydowns
|
| 11/21/2014 | BKCAHY | Moody’s revises Valeant to stable
|
| 6/18/2014 | BKCVDDEMIGPV | Market Commentary: West megadeal, NuvoTV, Wave Division offerings price; Valeant plans massive deal
|
| 6/18/2014 | BKHY | Valeant plans $7 billion loans, $12.35 billion bonds for Allergan bid
|
| 4/22/2014 | BKHY | Moody's revises Valeant outlook to developing
|
| 4/22/2014 | BK | Valeant Pharmaceuticals: Proposed merger has support of Allergan's largest stakeholder
|
| 4/21/2014 | BK | Valeant expects up to $15 billion commitments to fund Allergan merger
|
| 1/7/2014 | BKHYLM | Valeant Pharmaceuticals reiterates 2013 guidance, eyes 40% increase in 2014
|
| 12/18/2013 | BK | Market Commentary: Multiple deals break; Allison, Darling, Alcatel, ARC, Open Text, HydroChem, Vantage revised
|
| 12/18/2013 | BK | Valeant Pharmaceuticals finalizes term loan E size at $2.95 billion
|
| 12/16/2013 | BK | Valeant reduces term loan size, firms pricing at Libor plus 300 bps
|
| 12/5/2013 | BK | Valeant Pharmaceuticals details term loan A extension request
|
| 12/5/2013 | BKCVHY | S&P rates Valeant loan BB
|
| 12/4/2013 | BK | Valeant Pharmaceuticals to launch $3.18 billion term loan on Thursday
|
| 11/15/2013 | BKHY | S&P assigns Valeant notes B
|
| 11/15/2013 | BKHY | Moody's gives Valeant notes B1
|
| 9/12/2013 | BK | Market Commentary: Activision, Biomet, Steinway, Capsugel break; Valeant tweaks deal; JBS books shut early
|
| 9/10/2013 | BKHY | S&P rates Valeant loans BB
|
| 9/9/2013 | BK | Valeant launches repricing of term loan C and term loan D debt
|
| 9/9/2013 | BK | Market Commentary: Neiman softens on buyout news; Biomet, Steinway revise deadlines; Nine, Pinnacle tweak deals
|
| 8/6/2013 | BK | Market Commentary: Playa Funding frees up above OID; U.S. Renal Care, TIP Trailer Services rework deals
|
| 6/27/2013 | BK | Market Commentary: Valeant, TransDigm, Blue Coat Systems, CHG break; number of primary deals revised
|
| 6/27/2013 | BK | Valeant trims term B to $3.2 billion, ups term A to $850 million
|
| 6/25/2013 | BK | Valeant lifts spread on $3.55 billion term B to Libor plus 375 bps
|
| 6/25/2013 | BK | Market Commentary: Hargray Communications, Custom Ecology hit secondary; Armacell, Valeant revise deals
|
| 6/19/2013 | BK | Market Commentary: National Financial, Navios free up; Websense, BlackPearl, Clearwater, LANDesk revised
|
| 6/19/2013 | BK | Valeant Pharmaceuticals launches $4.05 billion in term A and B debt
|
| 6/19/2013 | BKCVHY | S&P lowers Valeant, rates new term loans BB, notes B
|
| 6/19/2013 | BKCVHY | Moody's: Valeant notes B1, loans Ba1
|
| 6/18/2013 | BK | Market Commentary: Formula One, Stallion, Harron, Nine break; Beats, Travelport, State Class revise deals
|
| 6/18/2013 | BK | Valeant Pharmaceuticals to launch $4.3 billion in loans on Wednesday
|
| 5/31/2013 | BKHY | Valeant Pharmaceuticals gets $9.28 billion bridge loan commitment
|
| 5/30/2013 | BKHY | Valeant holds lender call, reveals expected financing for Bausch buy
|
| 5/28/2013 | BKHY | Moody's affirms Valeant
|
| 5/28/2013 | BKHY | Valeant Pharmaceuticals plans loans, bonds for Bausch + Lomb buy
|
| 5/28/2013 | BKHY | S&P: Valeant Pharmaceuticals on negative watch
|
| 2/19/2013 | BK | Market Commentary: Valeant, Deltek, Bragg, Univar, Colfax break; Clear Channel trades higher with numbers
|
| 2/12/2013 | BKCAHY | S&P rates Valeant loans BBB-
|
| 2/7/2013 | BK | Market Commentary: Secondary sees surge of loans break; Tervita, Saxon Energy, PQ, Weather Channel update deals
|
| 2/7/2013 | BK | Valeant Pharmaceuticals to launch $2.3 billion in term loans on Friday
|
| 1/17/2013 | BKCVHY | S&P rates Valeant loan BBB-
|
| 1/4/2013 | BK | Market Commentary: Valeant releases full-year guidance, loans firm; NFR Energy sets second-lien price talk
|
| 1/4/2013 | BKCAHY | Valeant Pharmaceuticals targets revenue of up to $4.8 billion, 35% increase in EPS for 2013
|
| 9/27/2012 | BK | Market Commentary: TriZetto, Pep Boys, Valeant, Ollie's break; Getty, AdvancePierre, CAMP tweak deals
|
| 9/27/2012 | BK | Valeant Pharmaceuticals sets par price on repriced $1.3 billion loan
|
| 9/25/2012 | BK | Market Commentary: Sheridan, ADS, Cannery, Allison break; Zayo down with repricing; TriZetto moves deadline
|
| 9/25/2012 | BK | Valeant flexes $1 billion incremental term B to Libor plus 325 bps
|
| 9/14/2012 | BK | Valeant talks $1 billion incremental term B at Libor plus 375 bps
|
| 9/14/2012 | BK | Market Commentary: Cengage up with amend/extend chatter; Reynolds dips on paydown; FoxCo breaks above OID
|
| 9/13/2012 | BKCAHY | Moody's rates Valeant loan Ba1, notes B1
|
| 9/12/2012 | BK | Market Commentary: FTS rises with amendment; CPG shutting early; FoxCo tweaks deal; Nuveen finalizes OID
|
| 9/12/2012 | BK | Valeant sets Friday launch for $1 billion incremental term loan B
|
| 9/7/2012 | BKCAHY | Valeant's acquisition of Medicis expected to generate $1.75 billion bonds, $1 billion term loan
|
| 9/7/2012 | BK | Valeant Pharmaceuticals in talks on credit facility amendment
|
| 9/7/2012 | BKCAHY | S&P rates Valeant loan BBB-, notes BB-
|
| 9/5/2012 | BKCAHY | S&P affirms Valeant
|
| 9/4/2012 | BK | Market Commentary: Claire's Stores rises with paydown; Valeant dips on acquisition; FoxCo, Ikaria set talk
|
| 9/4/2012 | BKCAHY | Moody's could cut Valeant
|
| 9/4/2012 | BKHY | Valeant gets $2.75 billion bridge commitment, plans term loan, bonds
|
| 7/2/2012 | BK | Valeant getting $100 million incremental loan at Libor plus 375 bps
|
| 6/29/2012 | BKCAHY | S&P rates Valeant loan BBB-
|
| 6/14/2012 | BK | Market Commentary: Zayo sets coupon, breaks; Avaya slides in trading; LANDesk revises pricing, discount
|
| 6/8/2012 | BK | Market Commentary: Ascena Retail, Ferrara, Valeant free up; Chesapeake rises; Realogy rallies with IPO news
|
| 6/8/2012 | BK | Valeant ups loan to $600 million, lifts spread to Libor plus 375 bps
|
| 6/5/2012 | BKCACVHY | S&P rates Valeant loan BBB-
|
| 6/5/2012 | BKCAHY | Moody's says Valeant debt is credit negative
|
| 6/1/2012 | BK | Valeant talks $500 million incremental term loan at discount of 971/2-98
|
| 5/30/2012 | BK | Market Commentary: Valeant dips with incremental plans; U.S. Foodservice rises; Applied Systems frees up
|
| 5/30/2012 | BK | Valeant plans launch of $500 million incremental term loan Thursday
|
| 2/8/2012 | BK | Market Commentary: Valeant, Blue Coat break; Caesars rises with amendment tweaks; Cequel accelerates deadline
|
| 2/6/2012 | BK | Market Commentary: Generac breaks; Valeant tweaks deal; Attachmate pulled; Hawaiian Telcom, Bragg set talk
|
| 2/6/2012 | BK | Valeant ups term B to $600 million, cuts spread to Libor plus 275 bps
|
| 1/31/2012 | BK | Market Commentary: Mediacom, Univision loans trade up; PennantPark may upsize; Valeant, Grifols, Cequel set talk
|
| 1/31/2012 | BK | Valeant launches $500 million term loan B at Libor plus 300 bps
|
| 1/31/2012 | BKCAHY | S&P rates Valeant loan BBB-
|
| 1/30/2012 | BK | Market Commentary: Morton's breaks; ThermaSys tightens pricing; TransDigm, Jarden, Schaeffler float talk
|
| 1/30/2012 | BK | Valeant Pharmaceuticals to launch $500 million term loan B on Tuesday.
|
| 1/30/2012 | BKCACVHY | Moody's rates Valeant loan Ba1
|
| 1/6/2012 | BKCAHY | Valeant gives cash flow guidance of roughly $1.2 billion for 2012
|
| 12/23/2011 | BK | Market Commentary: Hoffmaster first- and second-lien loans free up; ConvergEx cancels debt financed buyout
|
| 12/9/2011 | BK | Market Commentary: Fidelity, Michaels Stores, NPC, Ocwen break; Valeant tweaks deal; 99 Cents shutting early
|
| 12/9/2011 | BK | Valeant Pharmaceuticals upsizes incremental term loan to $500 million
|
| 11/30/2011 | BK | Valeant Pharmaceuticals launches $350 million incremental term loan
|
| 11/30/2011 | BK | Market Commentary: Colfax, FleetPride, National Healing break; NCO, Six Flags, Endurance, Phoenix set talk
|
| 10/21/2011 | BK | Market Commentary: Compass Group, UPC deals allocate; BarrierSafe tightens price talk; synthetics seen higher
|
| 10/21/2011 | BK | Valeant Pharmaceuticals closes on $2 billion of pro rata loans
|
| 10/17/2011 | BK | Market Commentary: Cengage dips in soft market; Kinetic reworks structure; RegionalCare outlines tranching
|
| 10/17/2011 | BK | Valeant ups revolver to $275 million, term loan A to $1.225 billion
|
| 9/28/2011 | BKCAHY | Moody's: Valeant notes Baa3
|
| 9/28/2011 | BK | Commitments for Valeant Pharmaceuticals $1.7 billion credit facility due Oct. 5
|
| 9/28/2011 | BK | Market Commentary: Go Daddy breaks, trades higher; Compass Group sets pricing; cash loans, LCDX both end softer
|
| 9/28/2011 | BKCAHY | S&P ups Valeant, rates loans
|
| 9/23/2011 | BK | Market Commentary: Sealed Air, Blackboard first-lien, Buffalo break; BJ's tweaks OID; DigitalGlobe sets talk
|
| 9/23/2011 | BK | Valeant talks loan at Libor plus 250-300 bps, based on leverage
|
| 9/20/2011 | BK | Market Commentary: First Data, Freescale up in strong market; Avis Budget, Garden Ridge, Sealed Air rework deals
|
| 9/20/2011 | BK | Valeant Pharmaceuticals sets Thursday launch for $1.7 billion loan
|
| 5/26/2011 | BKCAHY | S&P affirms Valeant
|
| 3/30/2011 | BK | Valeant anticipates needing $6.7 billion of debt for Cephalon bid
|
| 3/30/2011 | BKCACVHY | S&P puts Valeant on watch
|
| 3/30/2011 | BKCACVHY | Moody's may cut Valeant
|
| 3/29/2011 | BKHY | Valeant makes bid for Cephalon that would be all debt financed
|
| 11/19/2010 | BKCACVHY | Moody's: Valeant unchanged
|
| 11/18/2010 | BK | Valeant Pharmaceuticals to pay down B loan with senior notes proceeds
|
| 11/18/2010 | BK | Market Commentary: Dunkin', AZ Chem, Hanger, Rural break; Burlington pulled, loan slides; Petco revises deal
|
| 11/18/2010 | BKHY | Moody's upgrades Valeant loans, rates notes B1
|
| 9/21/2010 | BK | Market Commentary: Valeant sets sizes, breaks; Tomkins frees up; Advance Pierre tweaks deal; Angelica sets talk
|
| 9/21/2010 | BK | Valeant firms term loan B at $625 million, A loan at $1 billion
|
| 9/17/2010 | BK | Market Commentary: United Components breaks; GenOn, Valeant tweak deals; Denny's firms pricing; RBS OID revealed
|
| 9/17/2010 | BK | Valeant Pharmaceuticals re-tranches credit facility, updates pricing
|
| 9/13/2010 | BK | Market Commentary: Cengage rises; Valeant, Fortress talk, Reynolds OIDs emerge; United Components moves deadline
|
| 9/13/2010 | BK | Valeant Pharmaceuticals sets talk on $1.875 billion credit facility
|
| 9/10/2010 | BK | Market Commentary: Burger King, Reynolds Group fix meetings; LCDX plows higher; Aspen Dental sets talk
|
| 9/8/2010 | BK | Market Commentary: Reynolds rolls out $1.5 billion, Visant talks term loan; LCDX finishes up 1/8 point
|
| 9/8/2010 | BK | Valeant launches $1.875 billion credit facility for Biovail merger
|
| 9/3/2010 | BK | Market Commentary: Skilled Healthcare rises; Tomkins sets launch, reveals structure; Oshkosh deal emerges
|
| 8/23/2010 | BK | Valeant sets Sept. 8 launch for $3.022 billion secured credit facility
|
| 8/23/2010 | BK | Market Commentary: Strategic Partners breaks; Advance Pierre structure emerges; Valeant firms timing; Cenveo pulled
|
| 8/11/2010 | BK | Market Commentary: Pinnacle Foods firms pricing, breaks; Toys 'R' Us rises; Medical Card, AMN, Chemtura set talk
|
| 8/11/2010 | BK | Valeant's $3.022 billion credit facility seen as September business
|
| 7/21/2010 | BK | Valeant gives banks room for change on $3.022 billion credit facility
|
| 6/23/2010 | BK | Valeant details structure, pricing on $3.022 billion credit facility
|
| 6/23/2010 | BK | Market Commentary: Clear Channel slides; Interactive Data, Ocwen set talk; GEO reveals OID; Kenan readies launch
|
| 6/21/2010 | BK | Valeant plans $3.05 billion credit facility for merger with Biovail
|
